Across all industries, the total number of companies on track to go public could make this week the most active for IPOs ...

Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Guggenheim Emerging Outlook: ...

The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.

A large biotech fund that's an insider at Cogent Biosciences recently sold millions of shares amid the company's best annual ...

A major biotech company has announced plans to lay off more than 100 positions from its Franklin, Massachusetts, facility.

WENZHOU, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- As the global pharmaceutical and healthcare ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

For biotech companies the past two years have been challenging. Biotech investments have not reached the record levels of ...

Cantai launched in 2023 with a $3 million seed round. The company has raised $6.55 million to date at an undisclosed valuation, according to PitchBook. It develops drug candidates with special ...

A surge in Inventiva shares, up about 50% in the first few weeks of 2026, highlights investors' appetite for ​betting on the ...

The business may not be as strong as its performance this year suggests.